Work

Figure S2 from Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone

Year: 2024

Type: other

Abstract: Osteoclast recruitment and bone disruption. A) RENCA VHL- cells (green, GFP); osteoclasts (red, TRAP); nuclei (blue, DAPI); white arrowhead, TRAP+ cells. Bar, 50 µm; B) UM-RC-3 (green, GFP); osteoclasts (red, TRAP); nuclei (blue, DAPI); white arrowhead, TRAP+ cells. Bar, 50 µm. Images captured by confocal microscope. TRAP-tartrate-resistant acid phosphatase. White rectangle, (i); magnification.

DOI: 10.1158/2767-9764.27187286

Authors: Stefan Maksimovic, Nina C. Boscolo, Ludovica La Posta, Sergio Barrios, Mohammad Jad Moussa, Emanuela Gentile, Pedro I. Pesquera, Wenjiao Li, Jianfeng Chen, Javier A. Gomez, Akshay Basi, Jared K. Burks, Christopher Alvarez-Breckenridge, Jianjun Gao, Matthew T. Campbell, Eleonora Dondossola

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4403227139

Cites:

Cited by:

Related to: 10